Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses.

Kuenzel S, Till A, Winkler M, Häsler R, Lipinski S, Jung S, Grötzinger J, Fickenscher H, Schreiber S, Rosenstiel P.

J Immunol. 2010 Feb 15;184(4):1990-2000. doi: 10.4049/jimmunol.0900557. Epub 2010 Jan 8.

2.

NLRC5 limits the activation of inflammatory pathways.

Benko S, Magalhaes JG, Philpott DJ, Girardin SE.

J Immunol. 2010 Aug 1;185(3):1681-91. doi: 10.4049/jimmunol.0903900. Epub 2010 Jul 7.

3.

A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hösel M, Büning H, Schwarzenbacher R, Kufer TA.

J Biol Chem. 2010 Aug 20;285(34):26223-32. doi: 10.1074/jbc.M110.109736. Epub 2010 Jun 10.

4.

The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements.

Yuan J, Wegenka UM, Lütticken C, Buschmann J, Decker T, Schindler C, Heinrich PC, Horn F.

Mol Cell Biol. 1994 Mar;14(3):1657-68.

5.

NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.

Neerincx A, Rodriguez GM, Steimle V, Kufer TA.

J Immunol. 2012 May 15;188(10):4940-50. doi: 10.4049/jimmunol.1103136. Epub 2012 Apr 6.

6.
10.

NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.

Staehli F, Ludigs K, Heinz LX, Seguín-Estévez Q, Ferrero I, Braun M, Schroder K, Rebsamen M, Tardivel A, Mattmann C, MacDonald HR, Romero P, Reith W, Guarda G, Tschopp J.

J Immunol. 2012 Apr 15;188(8):3820-8. doi: 10.4049/jimmunol.1102671. Epub 2012 Mar 12.

11.

Nucleotide-binding oligomerization domain-like receptors: intracellular pattern recognition molecules for pathogen detection and host defense.

Franchi L, McDonald C, Kanneganti TD, Amer A, Núñez G.

J Immunol. 2006 Sep 15;177(6):3507-13. Review.

12.

Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.

Tong Y, Cui J, Li Q, Zou J, Wang HY, Wang RF.

Cell Res. 2012 May;22(5):822-35. doi: 10.1038/cr.2012.53. Epub 2012 Apr 3.

13.

Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes.

Casarosa P, Gruijthuijsen YK, Michel D, Beisser PS, Holl J, Fitzsimons CP, Verzijl D, Bruggeman CA, Mertens T, Leurs R, Vink C, Smit MJ.

J Biol Chem. 2003 Dec 12;278(50):50010-23. Epub 2003 Sep 30.

14.

A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.

Paulus C, Krauss S, Nevels M.

Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3840-5. Epub 2006 Feb 23.

15.
17.

NLRC5 knockdown in chicken macrophages alters response to LPS and poly (I:C) stimulation.

Lian L, Ciraci C, Chang G, Hu J, Lamont SJ.

BMC Vet Res. 2012 Mar 8;8:23. doi: 10.1186/1746-6148-8-23.

18.

Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes.

Aittomäki S, Pesu M, Groner B, Jänne OA, Palvimo JJ, Silvennoinen O.

J Immunol. 2000 Jun 1;164(11):5689-97.

20.

Supplemental Content

Support Center